Clorox (CLX)
(Delayed Data from NYSE)
$142.34 USD
-0.14 (-0.10%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $142.28 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for The Clorox Company falls in the month of June.
All items in Millions except Per Share data.
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 367 | 183 | 319 | 871 | 111 |
Receivables | 688 | 681 | 604 | 648 | 631 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 696 | 755 | 752 | 454 | 512 |
Other Current Assets | 77 | 106 | 154 | 47 | 51 |
Total Current Assets | 1,828 | 1,725 | 1,829 | 2,020 | 1,305 |
Net Property & Equipment | 1,345 | 1,334 | 1,302 | 1,103 | 1,034 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,964 | 2,442 | 2,493 | 2,471 | 2,503 |
Deposits & Other Assets | 462 | 315 | 378 | 328 | 274 |
Total Assets | 5,945 | 6,158 | 6,334 | 6,213 | 5,116 |
Liabilities & Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Notes Payable | 50 | 237 | 0 | 0 | 396 |
Accounts Payable | 1,659 | 1,469 | 1,675 | 1,329 | 1,035 |
Current Portion Long-Term Debt | 0 | 0 | 300 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 121 | 0 | 0 | 25 | 9 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,917 | 1,784 | 2,056 | 1,418 | 1,440 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 28 | 66 | 67 | 62 | 50 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,477 | 2,474 | 2,484 | 2,780 | 2,287 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 825 | 791 | 834 | 767 | 780 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,557 | 5,429 | 5,742 | 5,305 | 4,557 |
Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 131 | 131 | 131 | 159 | 159 |
Capital Surplus | 1,245 | 1,202 | 1,186 | 1,137 | 1,046 |
Retained Earnings | 583 | 1,048 | 1,036 | 3,567 | 3,150 |
Other Equity | -325 | -306 | -365 | -640 | -602 |
Treasury Stock | 1,246 | 1,346 | 1,396 | 3,315 | 3,194 |
Total Shareholder's Equity | 388 | 729 | 592 | 908 | 559 |
Total Liabilities & Shareholder's Equity | 5,945 | 6,158 | 6,334 | 6,213 | 5,116 |
Total Common Equity | 388 | 729 | 592 | 908 | 559 |
Shares Outstanding | 123.80 | 123.10 | 122.80 | 126.20 | 125.70 |
Book Value Per Share | 3.13 | 5.92 | 4.82 | 7.19 | 4.45 |
Fiscal Year End for The Clorox Company falls in the month of June.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 355 | 518 | 367 | 242 |
Receivables | NA | 679 | 581 | 688 | 678 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 655 | 710 | 696 | 735 |
Other Current Assets | NA | 115 | 102 | 77 | 90 |
Total Current Assets | NA | 1,804 | 1,911 | 1,828 | 1,745 |
Net Property & Equipment | NA | 1,314 | 1,317 | 1,345 | 1,315 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,950 | 1,949 | 1,964 | 1,972 |
Deposits & Other Assets | NA | 486 | 486 | 462 | 427 |
Total Assets | NA | 5,908 | 5,991 | 5,945 | 5,818 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 247 | 347 | 50 | 138 |
Accounts Payable | NA | 1,649 | 1,678 | 1,659 | 1,722 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 34 | 115 | 121 | 48 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 2,022 | 2,228 | 1,917 | 1,996 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 26 | 27 | 28 | 27 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,479 | 2,478 | 2,477 | 2,476 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 837 | 825 | 824 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 5,690 | 5,860 | 5,557 | 5,646 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 131 | 131 | 131 | 131 |
Capital Surplus | NA | 1,245 | 1,246 | 1,245 | 1,232 |
Retained Earnings | NA | 241 | 299 | 583 | 415 |
Other Equity | NA | -194 | -326 | -325 | -329 |
Treasury Stock | NA | 1,205 | 1,219 | 1,246 | 1,277 |
Total Shareholder's Equity | NA | 218 | 131 | 388 | 172 |
Total Liabilities & Shareholder's Equity | NA | 5,908 | 5,991 | 5,945 | 5,818 |
Total Common Equity | 0 | 218 | 131 | 388 | 172 |
Shares Outstanding | 124.10 | 124.10 | 124.00 | 123.80 | 123.60 |
Book Value Per Share | 0.00 | 1.76 | 1.06 | 3.13 | 1.39 |